NCT05740215 2023-02-22
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Shandong New Time Pharmaceutical Co., LTD
Phase 1/2 Unknown
Shandong New Time Pharmaceutical Co., LTD
Mabwell (Shanghai) Bioscience Co., Ltd.
Mabwell (Shanghai) Bioscience Co., Ltd.
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
The First People's Hospital of Lianyungang